James W Larrick
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$6.9MFederal grants as PI17 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
17 awards · $6.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 18, 2026 | NIH | SBIR Phase I Novel macrophage repolarization therapy for colorectal cancer | $387K | Panorama Research Incorporated |
| Sep 18, 2025 | NIH | SBIR Phase I Novel Therapy for Sarcopenia | $354K | Panorama Research Incorporated |
| Aug 14, 2024 | NIH | SBIR Phase I Novel therapy to prevent alveolar bone loss in severe periodontitis | $304K | Panorama Research Incorporated |
| Sep 26, 2023 | NIH | SBIR Phase I Novel therapy for arthrofibrosis | $276K | Panorama Research Incorporated |
| Aug 11, 2023 | NIH | SBIR Phase I Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia | $300K | Panorama Research Incorporated |
| Feb 1, 2019 | NIH | SBIR Phase II Monoclonal antibody for autoimmune disease | $905K | Panorama Research Incorporated |
| Aug 7, 2018 | NIH | SBIR Phase II Novel NMDA-targeted Therapy for Alzheimer's Disease | $711K | Panorama Research Incorporated |
| Feb 6, 2018 | NIH | SBIR Phase II Monoclonal antibody for autoimmune disease | $593K | Panorama Research Incorporated |
| Sep 9, 2017 | NIH | SBIR Phase II Novel NMDA-targeted Therapy for Alzheimer's Disease | $788K | Panorama Research Incorporated |
| Sep 16, 2016 | NIH | SBIR Phase I Novel therapy for erosive bone disease | $225K | Panorama Research Incorporated |
| Sep 8, 2016 | NIH | SBIR Phase I Hepcidin Antagonist Therapy for Anemia of Chronic Disease | $225K | Panorama Research Incorporated |
| Jun 30, 2016 | NIH | SBIR Phase I Novel Aminoadamantane Nitrates for the Treatment of Neurological Diseases | $225K | Panorama Research Incorporated |
| Jun 28, 2016 | NIH | SBIR Phase II Antibody-Membrane Switch (AMS) technology for optimized antibody engineering | $456K | Panorama Research Incorporated |
| Sep 17, 2015 | NIH | SBIR Phase I Novel NMDA Receptor Antagonists for Beta Cell Rescue | $225K | Panorama Research Incorporated |
| Jul 21, 2015 | NIH | SBIR Phase I Novel therapy for Netherton syndrome | $225K | Panorama Research Incorporated |
| Jun 15, 2015 | NIH | SBIR Phase I Monoclonal antibody for autoimmune disease | $225K | Panorama Research Incorporated |
| Jun 15, 2015 | NIH | SBIR Phase II Antibody-Membrane Switch (AMS) technology for optimized antibody engineering | $500K | Panorama Research Incorporated |
Peer ranks
Federal funding#145
Awards as PI#29
Patents#273
Companies
- Panorama Research IncorporatedLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.